Context Therapeutics Stock (NASDAQ: CNTX) stock price, news, charts, stock research, profile.
You can purchase shares of Context Therapeutics (NASDAQ:CNTX) through any online brokerage.
There are no as such competitors for Context Therapeutics.
Context Therapeutics has a consensus price target of $6.70.
The stock price for Context Therapeutics (NASDAQ: CNTX) is $0.98 last updated January 30, 2025 at 7:32 PM EST.
There are no upcoming dividends for Context Therapeutics.
Context Therapeutics’s Q4 earnings are confirmed for Thursday, March 20, 2025.
There is no upcoming split for Context Therapeutics.
Context Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.